Behavidence is a mental health application that generates a daily mental health score. It compares your digital behavior to other people with anxiety, depression and ADHD.
Location: United States, New York
Employees: 11-50
Total raised: $4.3M
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.03.2022 | Seed | $4.3M | - |
Mentions in press and media 11
| Date | Title | Description |
| 07.07.2026 | ew NHS Figures Raise a Question: Can Passive Digital Biomarkers Transform Mental Health Care? | Behavidence Clinician platform and Application Behavidence Mobile App New NHS data shows 2.26M people have open mental health referrals. Could passive digital biomarkers help clinicians deliver care more effectively? Healthcare systems arou... |
| 03.10.2024 | Behavidence Partners with CFG Health to Enhance Employee Mental Wellness in Correctional Facilities | CFG Health Logo Behavidence Mental Wellness App Behavidence Logo CFG Health employees to leverage cutting-edge AI technology from Behavidence for mental wellness management. By integrating this AI-driven technology, we are setting a new sta... |
| 24.07.2024 | Behavidence and Yuna.io Announce Groundbreaking Collaboration to make Mental Health support accurate and accessible | Yuna's AI-Powered therapy app Behavidence Logo Yuna.io Logo Behavidence and Yuna.io partner to enhance mental health support with real-time monitoring and AI-guided self therapy, offering accurate, timely interventions. this solution addres... |
| 08.07.2024 | New Behavidence Data Highlights Gender-Specific Behavioral Patterns in Depression | Behavidence Application Behavidence Care - Behavidence's Providers Platform Behavidence reveals key behavioral differences between depressed males and females, highlighting variations in mobile app usage patterns and inactivity times.. Unde... |
| 26.04.2023 | Essen Health Care and Behavidence Partner to Improve Mental Health Outcomes | Behavidence Logo Essen Health Care Logo The collaboration highlights the importance of using technology to improve adherence to therapy and develop effective coping mechanisms for patients Our digital phenotyping technology combined with Es... |
| 15.03.2022 | Behavidence Raises $4.3M to Expand AI-Driven Psychiatric & Neurological Disorders Monitoring | What You Should Know: – Behavidence, a behavioral health company that monitors psychiatric and neurological disorders using artificial intelligence, announced a $4.3M seed round led by Welltech Ventures, featuring Arc Impact and Longevity V... |
| 11.03.2022 | Behavidence Closes $4.3M Seed Round | NEW YORK, NY, Behavidence, a startup company that monitors psychiatric and neurological disorders, announced a $4.3 million seed round led by Welltech Ventures. >> Click here for more funding data on Behavidence >> To export... |
| 11.03.2022 | Behavidence Closes $4.3 Million Seed Round to Amplify its Artificial Intelligence Technology used to Detect, Screen and Monitor Mental Illness | Behavidence, a leading startup company that monitors psychiatric and neurological disorders using artificial intelligence, announced a $4.3 million seed round led by Welltech Ventures, featuring Arc Impact and Longevity Ventures. Founded in... |
| 11.03.2022 | Behavidence Closes $4.3M Seed Funding | Behavidence, a NYC-based provider of tools to monitor psychiatric and neurological disorders using artificial intelligence, raised $4.3M in Seed funding. The round was led by Welltech Ventures, with participation from Arc Impact and Longevi... |
| 10.03.2022 | Behavidence Closes $4.3 Million Seed Round to Amplify its Artificial Intelligence Technology used to Detect, Screen and Monitor Mental Illness | Today’s funding announcement demonstrates our investors’ support, commitment, and optimism for the future of Behavidence NEW YORK (PRWEB) March 10, 2022 Behavidence, a leading startup company that monitors psychiatric and neurological disor... |
Show more